Literature DB >> 23226899

Decision-making on malaria vaccine introduction: the role of cost-effectiveness analyses.

Vasee S Moorthy1, Raymond Hutubessy, Robert D Newman, Joachim Hombach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23226899      PMCID： PMC3506408          DOI： 10.2471/BLT.12.107482

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  12 in total

1.  Community-wide effects of permethrin-treated bed nets on child mortality and malaria morbidity in western Kenya.

Authors:  William A Hawley; Penelope A Phillips-Howard; Feiko O ter Kuile; Dianne J Terlouw; John M Vulule; Maurice Ombok; Bernard L Nahlen; John E Gimnig; Simon K Kariuki; Margarette S Kolczak; Allen W Hightower
Journal:  Am J Trop Med Hyg       Date:  2003-04       Impact factor: 2.345

2.  Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria.

Authors:  Nicolas Maire; Samuel D Shillcutt; Damian G Walker; Fabrizio Tediosi; Thomas A Smith
Journal:  Value Health       Date:  2011-08-15       Impact factor: 5.725

3.  First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Authors:  Selidji Todagbe Agnandji; Bertrand Lell; Solange Solmeheim Soulanoudjingar; José Francisco Fernandes; Béatrice Peggy Abossolo; Cornelia Conzelmann; Barbara Gaelle Nfono Ondo Methogo; Yannick Doucka; Arnaud Flamen; Benjamin Mordmüller; Saadou Issifou; Peter Gottfried Kremsner; Jahit Sacarlal; Pedro Aide; Miguel Lanaspa; John J Aponte; Arlindo Nhamuave; Diana Quelhas; Quique Bassat; Sofia Mandjate; Eusébio Macete; Pedro Alonso; Salim Abdulla; Nahya Salim; Omar Juma; Mwanajaa Shomari; Kafuruki Shubis; Francisca Machera; Ali Said Hamad; Rose Minja; Ali Mtoro; Alma Sykes; Saumu Ahmed; Alwisa Martin Urassa; Ali Mohammed Ali; Grace Mwangoka; Marcel Tanner; Halidou Tinto; Umberto D'Alessandro; Hermann Sorgho; Innocent Valea; Marc Christian Tahita; William Kaboré; Sayouba Ouédraogo; Yara Sandrine; Robert Tinga Guiguemdé; Jean Bosco Ouédraogo; Mary J Hamel; Simon Kariuki; Chris Odero; Martina Oneko; Kephas Otieno; Norbert Awino; Jackton Omoto; John Williamson; Vincent Muturi-Kioi; Kayla F Laserson; Laurence Slutsker; Walter Otieno; Lucas Otieno; Otsyula Nekoye; Stacey Gondi; Allan Otieno; Bernhards Ogutu; Ruth Wasuna; Victorine Owira; David Jones; Agnes Akoth Onyango; Patricia Njuguna; Roma Chilengi; Pauline Akoo; Christine Kerubo; Jesse Gitaka; Charity Maingi; Trudie Lang; Ally Olotu; Benjamin Tsofa; Philip Bejon; Norbert Peshu; Kevin Marsh; Seth Owusu-Agyei; Kwaku Poku Asante; Kingsley Osei-Kwakye; Owusu Boahen; Samuel Ayamba; Kingsley Kayan; Ruth Owusu-Ofori; David Dosoo; Isaac Asante; George Adjei; George Adjei; Daniel Chandramohan; Brian Greenwood; John Lusingu; Samwel Gesase; Anangisye Malabeja; Omari Abdul; Hassan Kilavo; Coline Mahende; Edwin Liheluka; Martha Lemnge; Thor Theander; Chris Drakeley; Daniel Ansong; Tsiri Agbenyega; Samuel Adjei; Harry Owusu Boateng; Theresa Rettig; John Bawa; Justice Sylverken; David Sambian; Alex Agyekum; Larko Owusu; Francis Martinson; Irving Hoffman; Tisungane Mvalo; Portia Kamthunzi; Ruthendo Nkomo; Albans Msika; Allan Jumbe; Nelecy Chome; Dalitso Nyakuipa; Joseph Chintedza; W Ripley Ballou; Myriam Bruls; Joe Cohen; Yolanda Guerra; Erik Jongert; Didier Lapierre; Amanda Leach; Marc Lievens; Opokua Ofori-Anyinam; Johan Vekemans; Terrell Carter; Didier Leboulleux; Christian Loucq; Afiya Radford; Barbara Savarese; David Schellenberg; Marla Sillman; Preeti Vansadia
Journal:  N Engl J Med       Date:  2011-10-18       Impact factor: 91.245

Review 4.  Immune effector mechanisms in malaria.

Authors:  K Marsh; S Kinyanjui
Journal:  Parasite Immunol       Date:  2006 Jan-Feb       Impact factor: 2.280

Review 5.  WHO Guide for standardisation of economic evaluations of immunization programmes.

Authors:  Damian G Walker; Raymond Hutubessy; Philippe Beutels
Journal:  Vaccine       Date:  2009-06-28       Impact factor: 3.641

6.  Predictions of the epidemiologic impact of introducing a pre-erythrocytic vaccine into the expanded program on immunization in sub-Saharan Africa.

Authors:  Nicolas Maire; Fabrizio Tediosi; Amanda Ross; Thomas Smith
Journal:  Am J Trop Med Hyg       Date:  2006-08       Impact factor: 2.345

7.  Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies.

Authors:  Jamie T Griffin; T Deirdre Hollingsworth; Lucy C Okell; Thomas S Churcher; Michael White; Wes Hinsley; Teun Bousema; Chris J Drakeley; Neil M Ferguson; María-Gloria Basáñez; Azra C Ghani
Journal:  PLoS Med       Date:  2010-08-10       Impact factor: 11.069

Review 8.  Insecticide-treated bed nets and curtains for preventing malaria.

Authors:  C Lengeler
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 9.  Acquired immunity to malaria.

Authors:  Denise L Doolan; Carlota Dobaño; J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.

Authors:  Raymond Hutubessy; Ana Maria Henao; Pem Namgyal; Vasee Moorthy; Joachim Hombach
Journal:  BMC Med       Date:  2011-05-12       Impact factor: 8.775
View more
  10 in total

1.  Case reduction and cost-effectiveness of the RTS,S/AS01 malaria vaccine alongside bed nets in Lilongwe, Malawi.

Authors:  Griffin J Bell; Matthew Loop; Hillary M Topazian; Michael Hudgens; Tisungane Mvalo; Jonathan J Juliano; Portia Kamthunzi; Gerald Tegha; Innocent Mofolo; Irving Hoffman; Jeffrey A Bailey; Michael Emch
Journal:  Vaccine       Date:  2020-04-30       Impact factor: 3.641

2.  Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults.

Authors:  Odilon Nouatin; Ulysse Ateba Ngoa; Javier Ibáñez; Jean Claude Dejon-Agobe; Benjamin Mordmüller; Jean Ronald Edoa; Fabrice Mougeni; Sina Brückner; Aurore Bouyoukou Hounkpatin; Meral Esen; Michael Theisen; Kabirou Moutairou; Stephen L Hoffman; Saadou Issifou; Adrian J F Luty; Marguerite M Loembe; Selidji Todagbé Agnandji; Bertrand Lell; Peter G Kremsner; Ayôla Akim Adegnika
Journal:  Vaccine       Date:  2020-05-05       Impact factor: 3.641

Review 3.  Paths to a malaria vaccine illuminated by parasite genomics.

Authors:  David J Conway
Journal:  Trends Genet       Date:  2015-01-22       Impact factor: 11.639

4.  Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.

Authors:  Henry M Peixoto; Marcelo A M Brito; Gustavo A S Romero; Wuelton M Monteiro; Marcus V G de Lacerda; Maria R F de Oliveira
Journal:  Malar J       Date:  2016-02-11       Impact factor: 2.979

5.  Costing RTS,S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: A generalizable approach drawing on publicly available data.

Authors:  Katya Galactionova; Melanie Bertram; Jeremy Lauer; Fabrizio Tediosi
Journal:  Vaccine       Date:  2015-10-28       Impact factor: 3.641

Review 6.  Endectocides as a complementary intervention in the malaria control program: a systematic review.

Authors:  Fereshteh Ghahvechi Khaligh; Abbas Jafari; Elena Silivanova; Mikhail Levchenko; Bahlol Rahimi; Saber Gholizadeh
Journal:  Syst Rev       Date:  2021-01-18

Review 7.  Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S.

Authors:  Katya Galactionova; Thomas A Smith; Melissa A Penny
Journal:  Malar J       Date:  2021-11-18       Impact factor: 2.979

8.  Modeling the public health impact of malaria vaccines for developers and policymakers.

Authors:  Julia K Nunes; Vicky Cárdenas; Christian Loucq; Nicolas Maire; Thomas Smith; Craig Shaffer; Kårstein Måseide; Alan Brooks
Journal:  BMC Infect Dis       Date:  2013-07-01       Impact factor: 3.090

9.  Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.

Authors:  Melissa A Penny; Robert Verity; Caitlin A Bever; Christophe Sauboin; Katya Galactionova; Stefan Flasche; Michael T White; Edward A Wenger; Nicolas Van de Velde; Peter Pemberton-Ross; Jamie T Griffin; Thomas A Smith; Philip A Eckhoff; Farzana Muhib; Mark Jit; Azra C Ghani
Journal:  Lancet       Date:  2015-11-06       Impact factor: 79.321

10.  Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi.

Authors:  Griffin J Bell; Matthew S Loop; Tisungane Mvalo; Jonathan J Juliano; Innocent Mofolo; Portia Kamthunzi; Gerald Tegha; Marc Lievens; Jeffrey Bailey; Michael Emch; Irving Hoffman
Journal:  BMC Public Health       Date:  2020-06-12       Impact factor: 3.295
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.